Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Expands By 3,700.0%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 3,800 shares, a growth of 3,700.0% from the February 13th total of 100 shares. Based on an average daily trading volume, of 126,800 shares, the short-interest ratio is presently 0.0 days.

CNBX Pharmaceuticals Stock Down 13.3 %

Shares of OTCMKTS:CNBX opened at $0.01 on Thursday. The company has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.01. CNBX Pharmaceuticals has a one year low of $0.01 and a one year high of $0.02.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.